Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sex differences in nevirapine rash.

S J Bersoff-Matcha1, W C Miller, J A Aberg

  • 1Washington University School of Medicine, St. Louis, MO 63141, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 19, 2000
PubMed
Summary

Women taking nevirapine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), face a significantly higher risk of severe rash and treatment discontinuation compared to men. Understanding these sex differences is crucial for safe and effective prescribing practices.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national strategy for a canadian limb loss and limb difference registry.

Canadian prosthetics & orthotics journal·2026
Same author

Influence of insurance type on healthcare utilization among rural people who use drugs.

Drug and alcohol dependence·2025
Same author

Detecting Changes in Comfort, Pain, and Mobility Over Clinical Milestones for Individuals With Lower Limb Loss.

Canadian prosthetics & orthotics journal·2024
Same author

Visualization of membrane localization and the functional state of CB<sub>2</sub>R pools using matched agonist and inverse agonist probe pairs.

Chemical science·2024
Same author

Predicting high quality of participation in adaptive snow-sports for individuals with disabilities: An exploratory study.

Psychology of sport and exercise·2023
Same author

A Mixed-methods Study on Prosthesis Use Among Older Canadians With Lower-limb Amputations.

Canadian prosthetics & orthotics journal·2023

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • HIV/AIDS Research

Background:

  • Nevirapine is a common nonnucleoside reverse transcriptase inhibitor (NNRTI) used in HIV treatment.
  • Rash is a frequent side effect, potentially limiting treatment adherence.
  • Previous studies indicated a higher incidence of severe rash in men, but further investigation into sex-based differences is warranted.

Purpose of the Study:

  • To investigate the association between sex and the risk of severe rash and treatment discontinuation in patients receiving nevirapine.
  • To quantify the risk of severe rash and its impact on therapy adherence in women compared to men.

Main Methods:

  • A multicenter, retrospective cohort study was conducted over a 5-year period.
  • Data from patients receiving nevirapine were analyzed to compare the incidence of severe rash and discontinuation rates between sexes.

Related Experiment Videos

  • Multivariate analysis was used to adjust for age and baseline CD4 cell count.

    • Main Results:

    • Women experienced a significantly higher risk of severe rash (Risk Ratio [RR], 8.31) and were more likely to discontinue nevirapine due to rash (RR, 4.5).
    • After adjusting for covariates, women had a 7-fold increased risk for severe rash and were 3.5 times more likely to discontinue therapy.
    • The P-values for these associations were statistically significant (P=.005 for rash, P=.0005 for discontinuation).

    Conclusions:

    • Significant sex differences exist in the occurrence and management of nevirapine-associated severe rash.
    • Women face a substantially higher risk of severe rash and subsequent treatment discontinuation.
    • Awareness of these disparities is essential for informed nevirapine prescription, particularly in women of reproductive age.